Background & AimsDuring aging, physiological changes in the stomach result in more tenuous gastric tissue that is less capable of repairing injury, leading to increased susceptibility to chronic ulceration. Spasmolytic polypeptide/trefoil factor 2–expressing metaplasia (SPEM) is known to emerge after parietal cell loss and during Helicobacter pylori infection, however, its role in gastric ulcer repair is unknown. Therefore, we sought to investigate if SPEM plays a role in epithelial regeneration.MethodsAcetic acid ulcers were induced in young (2–3 mo) and aged (18–24 mo) C57BL/6 mice to determine the quality of ulcer repair with advancing age. Yellow chameleon 3.0 mice were used to generate yellow fluorescent protein–expressing organoids fo...
BACKGROUND & AIMS: Loss of parietal cells causes the development of spasmolytic polypeptide-expressi...
International audienceOBJECTIVE: It is not known whether or not epithelial progenitors of the pylori...
OBJECTIVES: Spasmolytic polypeptide-expressing metaplasia (SPEM) develops as a preneoplastic lesion ...
Background & Aims: During aging, physiological changes in the stomach result in more tenuous gastric...
Background & AimsDuring aging, physiological changes in the stomach result in more tenuous gastric t...
The trefoil peptides spasmolytic polypeptide (SP), intestinal trefoil factor (ITF), and pS2 show lin...
Background & Aims: The peptic ulcer heals through a complex process, although the ulcer relapse ofte...
Gastric carcinogenesis involves the loss of parietal cells (oxyntic atrophy) and subsequent replacem...
The development of intestinal-type gastric cancer is preceded by loss of parietal cells (oxyntic atr...
BACKGROUND & AIMS: The loss of parietal cells from the fundic mucosa leads to the emergence of metap...
Gastric cancer in humans arises in the setting of oxyntic atrophy (parietal cell loss) and attendant...
Intestinal-type gastric adenocarcinoma evolves in a field of pre-existing metaplasia. Over the past ...
BACKGROUND & AIMS: Gastric cancer evolves in the setting of a pathologic mucosal milieu characterize...
Background & AimsThe peptic ulcer heals through a complex process, although the ulcer relapse often ...
OBJECTIVE: Metaplastic lineages in the oxyntic mucosa of the stomach are critical preneoplastic prec...
BACKGROUND & AIMS: Loss of parietal cells causes the development of spasmolytic polypeptide-expressi...
International audienceOBJECTIVE: It is not known whether or not epithelial progenitors of the pylori...
OBJECTIVES: Spasmolytic polypeptide-expressing metaplasia (SPEM) develops as a preneoplastic lesion ...
Background & Aims: During aging, physiological changes in the stomach result in more tenuous gastric...
Background & AimsDuring aging, physiological changes in the stomach result in more tenuous gastric t...
The trefoil peptides spasmolytic polypeptide (SP), intestinal trefoil factor (ITF), and pS2 show lin...
Background & Aims: The peptic ulcer heals through a complex process, although the ulcer relapse ofte...
Gastric carcinogenesis involves the loss of parietal cells (oxyntic atrophy) and subsequent replacem...
The development of intestinal-type gastric cancer is preceded by loss of parietal cells (oxyntic atr...
BACKGROUND & AIMS: The loss of parietal cells from the fundic mucosa leads to the emergence of metap...
Gastric cancer in humans arises in the setting of oxyntic atrophy (parietal cell loss) and attendant...
Intestinal-type gastric adenocarcinoma evolves in a field of pre-existing metaplasia. Over the past ...
BACKGROUND & AIMS: Gastric cancer evolves in the setting of a pathologic mucosal milieu characterize...
Background & AimsThe peptic ulcer heals through a complex process, although the ulcer relapse often ...
OBJECTIVE: Metaplastic lineages in the oxyntic mucosa of the stomach are critical preneoplastic prec...
BACKGROUND & AIMS: Loss of parietal cells causes the development of spasmolytic polypeptide-expressi...
International audienceOBJECTIVE: It is not known whether or not epithelial progenitors of the pylori...
OBJECTIVES: Spasmolytic polypeptide-expressing metaplasia (SPEM) develops as a preneoplastic lesion ...